Tolerance of Healthy Term Infants Fed Infant Formulas #4

Healthy Term Infants Clinical Trial

Official title:
Tolerance of Healthy Term Infants Fed Infant Formulas

Status Completed

Clinical Trial Summary

The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Healthy Term Infants

Clinical Trial Details

NCT number	NCT01155414
Study type	Interventional
Source	Abbott Nutrition
Contact
Status	Completed
Phase	Phase 3
Start date	March 2010
Completion date	July 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02646969` - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life	N/A
Terminated	`NCT01137877` - Growth and Tolerance of Healthy Term Infants to a New Infant Formula	Phase 3
Completed	`NCT04015050` - Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.	N/A
Completed	`NCT01497314` - Growth and Safety of a Low Lactose Milk-Based Infant Formula	N/A
Terminated	`NCT02221687` - The Combiotic-Study	N/A
Completed	`NCT00712608` - The Evaluation of Cow's Milk Formula - Study B	N/A